A Systematic Review of the Efficacy of Domperidone for the Treatment of Diabetic Gastroparesis

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 7, 2008, Pages 726-733

  Sugumar, Aravind ^a   Singh, Amanpal ^b   Pasricha, Pankaj Jay ^c  

^a MAYO CLINIC   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOMPERIDONE;

CLINICAL TRIAL; DIABETES MELLITUS; DRUG EFFICACY; HOSPITAL ADMISSION; HUMAN; PROLACTIN BLOOD LEVEL; REVIEW; SIDE EFFECT; STOMACH EMPTYING; STOMACH PARESIS; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT GAIN;

CLINICAL TRIALS AS TOPIC; DIABETES COMPLICATIONS; DOMPERIDONE; GASTROPARESIS; HUMANS; TREATMENT OUTCOME; UNITED STATES;

EID: 45849134924     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.02.065     Document Type: Review

References (38)

1. Loo F.D., Palmer D.W., Soergel K.H., et al. Gastric emptying in patients with diabetes mellitus. Gastroenterology 86 (1984) 485-494
2. Smith D.S., and Ferris C.D. Current concepts in diabetic gastroparesis. Drugs 63 (2003) 1339-1358
3. Vittal H., Farrugia G., Gomez G., et al. Mechanisms of disease: the pathological basis of gastroparesis-a review of experimental and clinical studies. Nat Clin Pract Gastroenterol Hepatol 4 (2007) 336-346
4. Champion M.C. Management of idiopathic, diabetic and miscellaneous gastroparesis with cisapride. Scand J Gastroenterol Suppl 165 (1989) 44-53
5. Dhir R., and Richter J.E. Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis. J Clin Gastroenterol 38 (2004) 237-242
6. Barone J.A. Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann Pharmacother 33 (1999) 429-440
7. Food and Drug Administration (Center for Drug Evaluation and Research). How to obtain domperidone (2006). http://www.fda.gov/cder/news/domperidone.htm
8. Ahmad N., Keith-Ferris J., Gooden E., et al. Making a case for domperidone in the treatment of gastrointestinal motility disorders. Curr Opin Pharmacol 6 (2006) 571-576
9. Reddymasu S.C., Soykan I., and McCallum R.W. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol 102 (2007) 2036-2045
10. Silvers D., Kipnes M., Broadstone V., et al. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group. Clin Ther 20 (1998) 438-453
11. Franzese A., Borrelli O., Corrado G., et al. Domperidone is more effective than cisapride in children with diabetic gastroparesis. Aliment Pharmacol Ther 16 (2002) 951-957
12. Horowitz M., Harding P.E., Chatterton B.E., et al. Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 30 (1985) 1-9
13. Patterson D., Abell T., Rothstein R., et al. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 94 (1999) 1230-1234
14. Koch K.L., Stern R.M., Stewart W.R., et al. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment. Am J Gastroenterol 84 (1989) 1069-1075
15. Braun A.P. Domperidone in the treatment of symptoms of delayed gastric emptying in diabetic patients. Adv Ther 6 (1989) 51-62
16. Nagler J., and Miskovitz P. Clinical evaluation of domperidone in the treatment of chronic postprandial idiopathic upper gastrointestinal distress. Am J Gastroenterol 76 (1981) 495-499
17. Heer M., Müller-Duysing W., Benes I., et al. Diabetic gastroparesis: treatment with domperidone-a double-blind, placebo-controlled trial. Digestion 27 (1983) 214-217
18. Watts G.F., Armitage M., Sinclair J., et al. Treatment of diabetic gastroparesis with oral domperidone. Diabet Med 2 (1985) 491-492
19. Soykan I., Sarosiek I., and McCallum R.W. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol 92 (1997) 976-980
20. Kozarek R. Domperidone for symptomatic management of diabetic gastroparesis in metoclopramide treatment failures. Adv Ther 7 (1990) 61-68
21. Stern W.R. Summary of the 34th meeting of the Food and Drug Administration Gastrointestinal Drugs Advisory Committee. March 15 and 16, 1989 (omeprazole and domperidone). Am J Gastroenterol 84 (1989) 1351-1355
22. Bingaman S., and Koch K. Long-term domperidone treatment for symptoms of gastroparesis in diabetic patients. Diabetes 46 (1997) 1204
23. Miller M., and Patterson D. Natural history of diabetic gastroparesis treated with cisapride or domperidone. Am J Gastroenterol 86 (1991) 1316 1316
24. Patterson D.J., Botoman V.A., Kozarek R.A., et al. Domperidone is effective long-term treatment for diabetic gastroparesis. Gastroenterology 100 (1991) A137
25. Patterson D., Koch K., Abell T., et al. A multicenter placebo-controlled study of domperidone in diabetic gastroparesis. Gastroenterology 104 (1993) A564
26. Patterson D., Meldrum N., and Kozarek R.M. Long-term efficacy of domperidone in patients with diabetes and symptoms of gastroparesis. Diabetes 46 (1997) 490
27. Lehmann K., and Patterson D.J. Does combination prokinetic therapy benefit patients with refractory diabetic gastroparesis?. Gastroenterology 108 (1995) A636
28. Koch K.L., Bingaman S., and Stern R.M. Withdrawal study of domperidone vs placebo in diabetic patients: effect on upper gastrointestinal symptoms and gastric myoelectrical activity. Gastroenterology 108 (1995) A630
29. Abell T.L., Rashed H., Cutts T., et al. Autonomic function is a determinant of quality of life improvement in response to domperidone therapy. Diabetes 46 (1997) 1445
30. Shifflett J., and McCallum R.W. Longterm efficacy, treatment outcome and quality of life in patients receiving chronic domperidone therapy for gastroparesis. Gastroenterology 108 (1995) A35
31. Champion M.C., Braaten J., and Gulenchyn K. Domperidone compared to cisapride in the management of gastroparesis. Am J Gastroenterol 86 (1991) 1309
32. Dumitrascu D.L., and Weinbeck M. Domperidone versus metoclopramide in the treatment of diabetic gastroparesis. Am J Gastroeneterol 95 (2000) 316-317
33. Champion M.C., Gulenchyn K., O'Leary T., et al. Domperidone improves symptoms and solid phase gastric emptying in diabetic gastroparesis. Am J Gastroenterol 82 (1987) 975
34. Schoenfeld P., Cook D., Hamilton F., et al. An evidence-based approach to gastroenterology therapy. Evidence-Based Gastroenterology Steering Group. Gastroenterology 114 (1998) 1318-1325
35. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
36. Harris R.P., Helfand M., Woolf S.H., et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 20 (2001) 21-35
37. Harvey J.A., Cowan III J.H., and LoRusso A.P. Increase in mammographic breast density associated with the use of domperidone. Breast J 10 (2004) 256-258
38. Wennbo H., and Tornell J. The role of prolactin and growth hormone in breast cancer. Oncogene 19 (2000) 1072-1076